More Than 210,000 Patients Supported with Impella® Heart Pumps
With today’s innovative technology, minimally invasive treatment options allow patients to recover the function of their native heart.
Patients and Caregivers
Protected PCI can be a safe treatment option to address severe coronary artery disease or advanced heart failure.
Health Care Professionals
Explore clinical data, educational opportunities and resources regarding the latest breakthroughs in cardiac and respiratory research.
Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology
January 12, 2022
Regulators Approve Impella 5.5® with SmartAssist® in Japan and Hong Kong; US FDA Grants Impella BTR® Conditional IDE Approval for First-in-Human Early Feasibility Study
January 10, 2022